original ) (raw )Administration of a gonadotropin-releasing hormone antagonist during the 3 days before the initiation of the in vitro fertilization/intracytoplasmic sperm injection treatment cycle: impact on ovarian stimulation. A pilot study
arianna riva
Fertility and Sterility, 2011
View PDFchevron_right
GnRH antagonists and mild ovarian stimulation for intrauterine insemination: a randomized study comparing different gonadotrophin dosages
Edgardo Somigliana
Human Reproduction, 2004
View PDFchevron_right
A randomized prospective trial comparing gonadotropin-releasing hormone (GnRH) antagonist/recombinant follicle-stimulating hormone (rFSH) versus GnRH-agonist/rFSH in women pretreated with oral contraceptives before in vitro fertilization
Samuel Chantilis
Fertility and Sterility, 2005
View PDFchevron_right
Comparing the effect of gonadotropin-releasing hormone agonist and human chorionic gonadotropin on final oocytes for ovulation triggering among infertile women undergoing intrauterine insemination: An RCT
Marzieh Zamaniyan
International Journal of Reproductive BioMedicine, 2017
View PDFchevron_right
Low-dose human chorionic gonadotropin may improve in vitro fertilization cycle outcomes in patients with low luteinizing hormone levels after gonadotropin-releasing hormone antagonist administration
Micah Hill
Fertility and Sterility, 2011
View PDFchevron_right
The addition of GnRH antagonists in intrauterine insemination cycles: a pilot study
Roberto Marci
PubMed, 2013
View PDFchevron_right
Prolongation of the follicular phase in in vitro fertilization results in a lower ongoing pregnancy rate in cycles stimulated with recombinant follicle-stimulating hormone and gonadotropin-releasing hormone antagonists
Michel Camus
Fertility and Sterility, 2004
View PDFchevron_right
Comparison of GNRH Agonist with Low-Dose Urinary HCG for the Induction of Final Oocyte Maturation in High-Risk Patients Undergoing Intracytoplasmic Sperm Injection-Embryo Transfer (Icsi-Et)
Faiz Alwaeely
Basrah Journal of Surgery, 2013
View PDFchevron_right
The use of gonadotropin-releasing hormone (GnRH) agonist to induce oocyte maturation after cotreatment with GnRH antagonist in high-risk patients undergoing in vitro fertilization prevents the risk of ovarian hyperstimulation syndrome: a prospective randomized controlled study
Claudio Benadiva
Fertility and Sterility, 2008
View PDFchevron_right
A randomized controlled trial of increasing recombinant follicle-stimulating hormone after initiating a gonadotropin-releasing hormone antagonist for in vitro fertilization-embryo transfer
Randal Robinson
Fertility and Sterility, 2006
View PDFchevron_right
Comparison of multiple dose GnRH antagonist and minidose long agonist protocols in poor responders undergoing in vitro fertilization: a randomized controlled trial
A. Pekin
Archives of Gynecology and Obstetrics, 2008
View PDFchevron_right
The effect of GnRH analogues for pituitary suppression on ovarian response in repeated ovarian stimulation cycles
Daniela Braga de Souza
Archives of Medical Science, 2011
View PDFchevron_right
The addition of GnRH antagonists in intrauterine insemination cycles with mild ovarian hyperstimulation does not increase live birth rates--a randomized, double-blinded, placebo-controlled trial
Donatella Caserta
Human Reproduction, 2011
View PDFchevron_right
Comparison of early versus late initiation of GnRH antagonist co-treatment for controlled ovarian stimulation in IVF: a randomized controlled trial
Frank Broekmans
Human Reproduction, 2013
View PDFchevron_right
Timing ovulation for intrauterine insemination with a GnRH antagonist
Eleuterio Hernandez
Human Reproduction, 2004
View PDFchevron_right
The effect of delayed initiation of gonadotropin-releasing hormone antagonist in a flexible protocol on in vitro fertilization outcome
Samer Tannus
Fertility and Sterility, 2013
View PDFchevron_right
Role of gonadotropin-releasing hormone antagonist in the management of subfertile couples with intrauterine insemination and controlled ovarian stimulation
Despina Tzanakaki
Fertility and Sterility, 2011
View PDFchevron_right
Initiation of Gonadotropin-Releasing Hormone Antagonist on Day 1 as Compared to Day 6 of Stimulation: Effect on Hormonal Levels and Follicular Development in in Vitro Fertilization Cycles
Michel Camus
The Journal of Clinical Endocrinology & Metabolism, 2003
View PDFchevron_right
Replacing GnRH agonists with GnRH antagonists in oocyte recipient cycle did not adversely affect the pregnancy rates
Elisabet Clua
European Journal of Obstetrics & Gynecology and Reproductive Biology, 2011
View PDFchevron_right
A randomized prospective study of early follicular or midluteal initiation of long protocol gonadotropin-releasing hormone in an in vitro fertilization program
Evelyn Cottell
Fertility and Sterility, 1996
View PDFchevron_right
Luteal phase and clinical outcome after human menopausal gonadotrophin/gonadotrophin releasing hormone antagonist treatment for ovarian stimulation in in-vitro fertilization/intracytoplasmic sperm injection cycles
Johan Smitz
Human Reproduction, 1999
View PDFchevron_right
The effects of adding Gonadotropin-releasing Hormone antagonist on cycle characteristics and pregnancy rate in stimulated Intrauterine Insemination (IUI) cycle
muayad sraibet
International Journal of Research in Pharmaceutical Sciences, 2020
View PDFchevron_right
Study of positive and negative consequences of using GnRH antagonist in intrauterine insemination cycle
maryam bagheri
View PDFchevron_right
Outcomes Comparison of In-Vitro Fertilization (IVF) between GnRH Agonist Trigger and hCG for Final Oocyte Maturation
Andon Hestiantoro
KnE Medicine, 2016
View PDFchevron_right
Reducing the dose of gonadotrophin-releasing hormone agonist on starting ovarian stimulation: effect on ovarian response and in-vitro fertilization outcome
Mohamed Elgendy
Human Reproduction, 1998
View PDFchevron_right
Substituting HCG with GnRH agonist to trigger final follicular maturation – a retrospective comparison of three different ovarian stimulation protocols
Roy Homburg
Reproductive BioMedicine Online, 2006
View PDFchevron_right
Profound LH suppression after GnRH antagonist administration is associated with a significantly higher ongoing pregnancy rate in IVF
E. Kolibianakis , Johan Schiettecatte
Human Reproduction, 2004
View PDFchevron_right
GnRH antagonists in ovarian stimulation for ICSI with oocyte restriction: a matched, controlled study
Jan Tesarik
Reproductive BioMedicine Online, 2007
View PDFchevron_right